FDA Launches Major Review of CGMPs

FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.

Related Content:

Regulatory Oversight and CompliancePharmaceutical Technology-10-02-2002

FDA Posts Slate of Seven Warning Letters Following Company Inspections

FDA Approves New Moderna COVID-19 Vaccine mNEXSPIKE

Geopolitical Shifts Change Nature of Pharma Partnerships